Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check48 days agoChange DetectedThe study has expanded from 255 to 280 locations, with numerous new sites added across the United States, Brazil, Europe, and Asia, while several previous sites have been removed.SummaryDifference9%
- Check55 days agoChange DetectedThe study expanded from 225 to 255 locations, with new sites added in various states including Florida, New Jersey, and New York, while several previous sites were removed, including those in Miami and Woodmere.SummaryDifference16%
- Check68 days agoChange DetectedThe latest update includes the addition of new locations and contact information for various research sites across the United States, Argentina, Canada, China, and Europe, while several previous locations and contacts have been withdrawn or removed.SummaryDifference40%
- Check82 days agoChange DetectedThe study has increased its locations from 208 to 209, with new contact details and updates for sites in Anaheim and Miami, while previous entries have been removed.SummaryDifference1%
- Check90 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check97 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.SummaryDifference1%
Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.